How Clean is Your Keyboard?
Greg S. Whiteley, PhD, School of Science and Health, Western Sydney University in Australia, and colleagues conducted a pilot study using three different sampling methods in a busy ICU to determine if and where MDROs might still be lurking in spite of routine environmental cleaning. The researchers traced the steps of healthcare workers (HCWs) in between their workstations and patient bedsides and sampled commonly touched objects along the way for MDROs.
The results show that 9 of 13 confirmed MDROs from any area came from clinical workstations — on chairs, clipboards, keyboards, telephones, and a computer mouse.
See Also: Automated Hand Hygiene Monitoring
As a secondary finding of the study, combined ATP testing on environmental surfaces was more than seven times as likely to positively identify MDROs as microbial swabbing (33.3 percent vs. 4.3 percent.). ATP testing is a process of rapidly measuring actively growing microorganisms through detection of adenosine triphosphate (ATP) — a marker of bio-contamination.
"In this pilot study, we found that many of the high touch objects from which MDROs were recovered were not items included in cleaning protocols," write Dr. Whiteley and co-authors. "The findings of this study suggest the need to review the hygiene standards adopted in the clinical workspace, away from the immediate patient zones in busy ICUs."
See Also: Clothing in NICU May Spread Respiratory Infections
The results also show that the use of rapid ATP testing in assessing cleanliness of high-touch objects in the ICU can improve the discovery rate for MDRO locations, the authors note.
While hand hygiene compliance by HCWs was not audited during the pilot study, the level of compliance is typically reported as adequate. This pilot study was part of a wider project, and other studies of the various components required for hygiene improvement within healthcare settings are currently under way.
Source: Elsevier Health Sciences
Image credit: Flickr.com
Published on : Mon, 7 Dec 2015
The Accelerate PhenoTest™ BC kit is the first application of the Accelerate Pheno™ system. It provides with less 5 minutes operator hands-on time within 1.5 hour the identification of the most prevalent micro-organisms seen in blood stream infections....
Always in sight, always in mind Features Mindray believes the best way to predict the future is to create it. The revolutionary BeneVision N22/N19 is designed to optimize user experience by satisfying all your clinical demands. With visionary-stimulating...
The fully-automated Accelerate Pheno™ system is designed to eliminate the lengthy culture and sample preparation steps required for most sample types prior to antimicrobial susceptibility testing. In addition, it hosts proprietary molecular identification...
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...